WST - West Pharmaceutical Services, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
1,767,400
1,717,400
1,599,100
1,509,100
1,399,800
Cost of Revenue
1,193,900
1,172,000
1,086,500
1,008,000
944,000
Gross Profit
573,500
545,400
512,600
501,100
455,800
Operating Expenses
Research Development
39,300
40,300
39,100
36,800
34,100
Selling General and Administrative
264,900
262,900
242,600
239,800
233,000
Total Operating Expenses
293,300
305,100
283,700
304,300
327,200
Operating Income or Loss
280,200
240,300
228,900
196,800
128,600
Interest Expense
8,600
6,300
6,500
7,000
12,500
Total Other Income/Expenses Net
2,100
6,700
-8,700
-31,400
-1,100
Income Before Tax
276,400
240,700
222,400
189,800
116,100
Income Tax Expense
54,500
41,400
80,900
54,400
26,300
Income from Continuing Operations
228,700
206,900
150,700
143,600
95,600
Net Income
228,700
206,900
150,700
143,600
95,600
Net Income available to common shareholders
228,700
206,900
150,700
143,600
95,600
Reported EPS
Basic
-
2.80
2.04
1.96
1.33
Diluted
-
2.74
1.99
1.91
1.30
Weighted average shares outstanding
Basic
-
73,900
73,900
73,300
72,000
Diluted
-
75,400
75,800
75,000
73,800
EBITDA
-
247,000
228,900
196,800
128,600